Strategies for preventing wheezing and asthma in small children

M Wickman1, E Melén, N Berglind

  • 1Department of Occupational and Environmental Health, Stockholm County Council, Stockholm, Sweden.

Allergy
|July 16, 2003
PubMed

Insights

Adhering to allergy prevention guidelines for breastfeeding, smoke-free homes, and managing dampness significantly reduced wheezing and asthma in 2-year-olds. This protective effect was most pronounced in children with a family history of allergies.

Area of Science:

  • Pediatric Allergy and Immunology
  • Environmental Health
  • Public Health

Background:

  • Allergy prevention guidelines aim to reduce the incidence of allergic diseases in children.
  • Factors such as breastfeeding, maternal smoking, and home environment play a role in childhood allergies.

Purpose of the Study:

  • To evaluate the impact of adherence to allergy preventive guidelines on the development of wheezing and asthma by age two.
  • To assess the effectiveness of guidelines concerning breastfeeding, maternal tobacco smoke exposure, and home dampness.

Main Methods:

  • A prospective birth cohort study (BAMSE) involving 4089 children born between 1994-1996 in Stockholm, Sweden.
  • Data collected via questionnaires on heredity, environmental factors at 2 months, and symptom assessment at 1 and 2 years of age.
  • Multiple logistic regression models were used to analyze the association between guideline adherence and wheezing/asthma outcomes.

Main Results:

  • Children following all guidelines had significantly lower rates of recurrent wheezing (12.6%) and asthma (6.8%) compared to those exposed to risk factors.
  • Adherence to guidelines showed a twofold reduction in asthma for children without allergic heredity and a threefold reduction for those with heredity.
  • The attributable fraction for asthma due to guideline adherence was 23% overall and 33% in children with allergic heredity.

Conclusions:

  • Family lifestyle aligned with allergy prevention guidelines is linked to a substantial decrease in recurrent wheezing and childhood asthma.
  • The benefits of these guidelines are particularly evident in children with a predisposition to allergies.
  • Further follow-up is needed to confirm the long-term risk reduction of these respiratory symptoms and diseases.
Abstract

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms: